Revenue
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Anaptysbio, Inc (ANAB)
Price$55.06Cached quote
Net income
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $234.6M | $91.3M | $17.2M | $10.3M | $63.2M | $75.0M | $8.0M | $5.0M | $10.0M | $16.7M | $17.6M |
| Research & development | $136.0M | $163.8M | $132.3M | $88.8M | $98.5M | $80.0M | $99.3M | $56.2M | $29.4M | $15.4M | $17.3M |
| Operating expenses | $186.7M | $206.2M | $181.6M | $125.4M | $120.0M | $98.9M | $115.4M | $71.7M | $38.8M | $19.7M | $20.9M |
| Operating income | $47.9M | −$114.9M | −$164.4M | −$115.2M | −$56.8M | −$23.9M | −$107.4M | −$66.7M | −$28.8M | −$3.0M | −$3.3M |
| Operating margin | 20.42% | −125.93% | −958.27% | −1,119.41% | −89.93% | −31.84% | −1,342.90% | −1,334.44% | −287.81% | −18.13% | −18.91% |
| EBITDA | $48.5M | −$114.3M | −$163.8M | −$114.5M | −$56.2M | −$23.3M | −$106.9M | −$66.4M | −$28.6M | −$2.8M | −$3.0M |
| EBITDA margin | 20.65% | −125.27% | −954.47% | −1,112.85% | −88.95% | −31.09% | −1,336.48% | −1,328.14% | −285.98% | −16.73% | −17.35% |
| Net income | −$13.2M | −$145.2M | −$163.6M | −$128.7M | −$57.8M | −$19.9M | −$97.3M | −$61.7M | −$30.1M | −$4.3M | −$5.4M |
| Net profit margin | −5.64% | −159.10% | −953.66% | −1,251.33% | −91.49% | −26.57% | −1,216.70% | −1,233.12% | −300.70% | −25.53% | −30.76% |
| Basic EPSper basic share | -$0.46 | -$5.12 | -$6.08 | -$4.57 | -$2.11 | -$0.73 | -$3.60 | -$2.50 | -$1.52 | -$1.62 | -$2.12 |
| Diluted EPSper diluted share | -$0.46 | -$5.12 | -$6.08 | -$4.57 | -$2.11 | -$0.73 | -$3.60 | -$2.50 | -$1.52 | -$1.62 | -$2.12 |
Owners
Reported shareholders
Reported holdings Number of shares
View holders
| Holder | Shares held |
|---|---|
EcoR1 Capital, LLC | 7.88M |
BlackRock, Inc. | 1.84M |
TANG CAPITAL MANAGEMENT LLC | 1.33M |
STATE STREET CORP | 1.29M |
VANGUARD CAPITAL MANAGEMENT LLC | 906.23K |
Affinity Asset Advisors, LLC | 826.11K |
Sanofi | 821.92K |
MILLENNIUM MANAGEMENT LLC | 807.32K |
Woodline Partners LP | 717.01K |
683 Capital Management, LLC | 660K |
GEODE CAPITAL MANAGEMENT, LLC | 637.87K |
Palo Alto Investors LP | 603.49K |
GOLDMAN SACHS GROUP INC | 584.07K |
First Light Asset Management, LLC | 582K |
D. E. Shaw & Co., Inc. | 539.67K |
VANGUARD PORTFOLIO MANAGEMENT LLC | 527.86K |
Apis Capital Advisors, LLC | 497K |
Faga Daniel | 495.97K |
Sofinnova Investments, Inc. | 493.54K |
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 488.65K |
Bars compare reported share counts. A matching total for this share class and reporting period is unavailable, so percentages are not shown.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Mar 30, 2026Form 4 | Schmid John P.Director | SellCommon Stock | 522 | $57.40 | $30.0K | 31.6K |
| Mar 30, 2026Form 4 | Schmid John P.Director | SellCommon Stock | 7.5K | $56.70 | $426.8K | 32.1K |
| Mar 30, 2026Form 4 | Schmid John P.Director | SellCommon Stock | 12.6K | $55.71 | $701.7K | 39.7K |
| Mar 27, 2026Form 4 | Faga DanielPresident, CEO | SellCommon Stock | 100 | $65.99 | $6.6K | 496.0K |
| Mar 27, 2026Form 4 | Faga DanielPresident, CEO | SellCommon Stock | 3.0K | $65.20 | $198.1K | 496.1K |